Disrupting the Scaffold to Improve Focal Adhesion Kinase–Targeted Cancer Therapeutics | Science Signaling

Skip to main content

ScienceMag.org

Article Information

vol. 6 no. 268 pe10

DOI:

https://doi.org/10.1126/scisignal.2004021

PubMed:

Published By:

Science Signaling

Print ISSN:

Online ISSN:

History:

.

Article Versions

Previous version (March 19, 2013 - 13:03).
You are viewing the most recent version of this article.

Copyright & Usage:

Copyright © 2013, American Association for the Advancement of Science

Author Information

William G. Cance¹,²,³,*,
Elena Kurenova¹,³,
Timothy Marlowe¹, and
Vita Golubovskaya¹,³

¹Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
²Department of Surgery, University at Buffalo, State University of New York, Elm and Carlton Streets, Buffalo, NY 14263, USA.
³CureFAKtor Pharmaceuticals, LLC, 14 Rockdove Lane, Orchard Park, NY 14127, USA.

↵*Corresponding author. E-mail: william.cance{at}roswellpark.org

Altmetric

Article usage

Article usage: March 2013 to August 2019

	Abstract	Full	Pdf
Mar 2013	1013	123	248
Apr 2013	788	85	155
May 2013	222	15	43
Jun 2013	169	19	40
Jul 2013	147	12	15
Aug 2013	103	7	15
Sep 2013	120	19	36
Oct 2013	157	10	29
Nov 2013	133	20	29
Dec 2013	118	15	17
Jan 2014	128	20	28
Feb 2014	99	19	24
Mar 2014	82	4	9
Apr 2014	71	17	13
May 2014	95	5	8
Jun 2014	99	11	15
Jul 2014	58	13	10
Aug 2014	38	23	9
Sep 2014	53	14	22
Oct 2014	54	19	12
Nov 2014	45	12	14
Dec 2014	45	10	11
Jan 2015	31	10	7
Feb 2015	24	4	7
Mar 2015	35	10	12
Apr 2015	34	5	13
May 2015	34	9	14
Jun 2015	32	3	8
Jul 2015	27	4	11
Aug 2015	28	2	10
Sep 2015	58	3	3
Oct 2015	27	3	9
Nov 2015	20	4	3
Dec 2015	49	2	4
Jan 2016	64	1	7
Feb 2016	37	2	14
Mar 2016	54	8	13
Apr 2016	16	0	4
May 2016	30	5	3
Jun 2016	46	1	3
Jul 2016	55	4	4
Aug 2016	44	5	6
Sep 2016	68	1	3
Oct 2016	49	3	5
Nov 2016	54	0	2
Dec 2016	48	7	6
Jan 2017	49	3	7
Feb 2017	58	7	7
Mar 2017	49	2	2
Apr 2017	29	1	3
May 2017	39	5	3
Jun 2017	32	2	0
Jul 2017	37	4	2
Aug 2017	60	3	5
Sep 2017	44	2	4
Oct 2017	34	3	4
Nov 2017	37	3	4
Dec 2017	24	1	3
Jan 2018	39	4	8
Feb 2018	52	2	2
Mar 2018	43	4	2
Apr 2018	53	6	7
May 2018	60	1	2
Jun 2018	48	4	3
Jul 2018	35	4	2
Aug 2018	35	11	6
Sep 2018	41	2	2
Oct 2018	45	6	2
Nov 2018	35	8	0
Dec 2018	54	3	1
Jan 2019	29	9	4
Feb 2019	44	6	1
Mar 2019	30	5	4
Apr 2019	8	5	4
May 2019	14	3	3
Jun 2019	19	1	0
Jul 2019	18	3	2
Aug 2019	10	5	3

Science Signaling: 6 (268)

Science Signaling

Vol 6, Issue 268
26 March 2013

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Signaling.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Disrupting the Scaffold to Improve Focal Adhesion Kinase–Targeted Cancer Therapeutics

Message Subject (Your Name) has forwarded a page to you from Science Signaling

Message Body (Your Name) thought you would like to see this page from the Science Signaling web site.

Your Personal Message
Download Powerpoint
Print
Save to my folders

Log In with your AAAS Login
Alerts

Please log in to add an alert for this article.

Log In with your AAAS Login

Sign In to Email Alerts with your Email Address
Email
Citation tools
Disrupting the Scaffold to Improve Focal Adhesion Kinase–Targeted Cancer Therapeutics

By William G. Cance, Elena Kurenova, Timothy Marlowe, Vita Golubovskaya

Science Signaling26 Mar 2013 : pe10

Targeting the scaffold of focal adhesion kinase is a therapeutic opportunity to inhibit signaling pathways selectively in cancer cells.

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share

Disrupting the Scaffold to Improve Focal Adhesion Kinase–Targeted Cancer Therapeutics

By William G. Cance, Elena Kurenova, Timothy Marlowe, Vita Golubovskaya

Science Signaling26 Mar 2013 : pe10

Targeting the scaffold of focal adhesion kinase is a therapeutic opportunity to inhibit signaling pathways selectively in cancer cells.

Share This Article:

Citing Articles in: